Varonis Systems에 대한 매도 수량은 투자자에게 Varonis Systems의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Varonis Systems (NASDAQ:VRNS) 주식, 공매도 수량 보고

Varonis Systems

Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2004 and went public in 2014.

Varonis Systems Inc

<a href="https://www.globenewswire.com/Tracker?data=qfkJWKAhTNtJJIEUSmyqBuWyUd43twp95nH4hnsL4OQ-lkGylYsFt7hsxLmBMkwpITSI9gw7ioMg2OahCTebJWB1LEcpyf4DhXc5k5h651w=">Varonis Systems, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) today announced at Dreamforce 2024 new capabilities that help customers automatically identify and eliminate data security risks. With this new release, Varonis introduced four remediation features, adding to its library of powerful automations that help ensure always-on data security across your data estate. &nbsp;
Unlike other tools that only surface problems, Varonis shows where sensitive data is at risk and solves issues at scale with automation. Varonis helps customers understand their Salesforce data security posture in real time and helps ensure only the right people can access sensitive data. Varonis identifies misconfigurations, excessive permissions, and suspicious activity that put data at risk.

News

VRNS

Varonis Expands Salesforce Security Offering With New Automated Remediation Capabilities

Varonis Systems's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NYSE">VRNS</a>) short percent of float has fallen 11.27% since its last report. The company recently reported that it has 9.52 million shares sold short, which is 10.87% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Varonis Systems Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1726085712_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Varonis Systems has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Varonis Systems's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Varonis Systems's peer group average for short interest as a percentage of float is 3.49%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Peering Into Varonis Systems's Recent Short Interest

The Notes will be unsecured senior obligations of the Company. The Notes will mature on September 15, 2029, unless earlier converted, redeemed or repurchased. Interest will accrue on the Notes at a rate of&nbsp;1.00%&nbsp;per year and will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2025.

Reported Earlier, Varonis Systems Prices Upsized $400M Of 1.00% Convertible Senior Notes Due 2029

WIIM

Varonis Systems shares are trading lower after the company announced it intends to offer $350 million of convertible senior notes due in 2029 via a private offering.

Offerings

Varonis Systems Intends To Offer $350M Of Convertible Senior Notes Due 2029 In Private Offering

Across the recent three months, 13 analysts have shared their insights on Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Varonis Systems, revealing an average target of $58.92, a high estimate of $67.00, and a low estimate of $48.00. This upward trend is evident, with the current average reflecting a 8.81% increase from the previous average price target of $54.15.
<img src="https://www.benzinga.com/files/images/story/2024/1724684411_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Varonis Systems. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$67.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$67.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Shaul Eyal</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$65.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$65.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Rob Owens</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$48.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Andrew Nowinski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$48.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Joel Fishbein</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$60.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Shyam Patil</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$65.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Shrenik Kothari</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$60.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Shrenik Kothari</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$52.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Saket Kalia</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$55.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Brian Essex</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Varonis Systems. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Varonis Systems compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Varonis Systems's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Varonis Systems's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/VRNS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Varonis Systems analyst ratings.</a>
<h2>All You Need to Know About Varonis Systems</h2>
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2004 and went public in 2014.
<h3>Financial Insights: Varonis Systems</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Varonis Systems displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 12.93%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Varonis Systems's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -18.37%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Varonis Systems's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -5.26%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Varonis Systems's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -2.23%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Varonis Systems's debt-to-equity ratio is below the industry average at 0.65, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Cracking The Code: Understanding Analyst Reviews For Varonis Systems

Wedbush analyst Daniel Ives reiterates Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Outperform and maintains $67 price target.

Price Target

Reiteration

Wedbush Reiterates Outperform on Varonis Systems, Maintains $67 Price Target

Varonis Systems's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NYSE">VRNS</a>) short percent of float has risen 12.59% since its last report. The company recently reported that it has 10.64 million shares sold short, which is 12.25% of all regular shares that are available for trading. Based on its trading volume, it would take traders 9.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Varonis Systems Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1723212023_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Varonis Systems has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Varonis Systems's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Varonis Systems's peer group average for short interest as a percentage of float is 5.45%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Varonis Systems?

MSFT

Varonis Systems Announces New Integrations With SentinelOne And Microsoft Defender For Endpoint At Black Hat USA 2024; Enhances Managed Data Detection And Response Capabilities For Faster Attack Mitigation And More Conclusive Investigations

Shares of Merck &amp; Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) fell sharply during Tuesday's session after the company reported second-quarter financial results and cut its FY24 adjusted EPS <a href="https://www.benzinga.com/general/biotech/24/07/40036607/mercks-q2-earnings-revenue-and-eps-beat-helped-by-strong-keytruda-sales-but-acquisition-costs-bit">guidance below estimates</a>.
Merck reported second-quarter sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Merck shares dipped 9.5% to $115.50 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Imunon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMNN#NASDAQ">IMNN</a>) shares jumped 147.8% to $2.9250 after the company announced topline results from its Phase 2 OVATION 2 study with IMNN-001. The results showed an 11.1-month improvement in median overall survival compared to standard-of-care alone in the intent-to-treat population.</li>
<li>Agape ATP Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATPC#NASDAQ">ATPC</a>) surged 97% to $0.1731. AGAPE ATP strengthened wellness division via innovative incubation with emerging local SMEs.</li>
<li>Processa Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares climbed 53% to $2.60 after the company announced FDA clearance of its IND application for a Phase 2 clinical trial of NGC-Cap in breast cancer.</li>
<li>INVO Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) gained 33% to $1.1513.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) shares gained 29% to $0.3850.</li>
<li>2U, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) jumped 28% to $3.4018.</li>
<li>CalciMedica, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALC#NASDAQ">CALC</a>) jumped 26.3% to $5.24.</li>
<li>JetBlue Airways Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) rose 20.6% to $7.16 after the company reported better-than-expected second-quarter financial results.</li>
<li>Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) rose 19.1% to $2.3050.</li>
<li>Commvault Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) gained 19.1% to $146.77 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company raised its FY25 revenue guidance.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) climbed 18.8% to $13.96 after the company reported better-than-expected second-quarter financial results and issued third-quarter revenue guidance above estimates.</li>
<li>Meta Data Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIU#NYSE">AIU</a>) gained 18.8% to $5.42.</li>
<li>Enveric Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) rose 18.3% to $0.59 after jumping around 6% on Monday.</li>
<li>Inspirato Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) gained 18.3% to $6.20 after jumping over 50% on Monday.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) shares gained 15.9% to $98.13 after the company reported better-than-expected second-quarter financial results and issued its third-quarter earnings guidance above estimates.</li>
<li>NeoGenomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) gained 16.1% to $17.00 following upbeat earnings.</li>
<li>Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) rose 16.1% to $2.1250 after the company reported better-than-expected quarterly financial results.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) gained 15.5% to $97.79 after the company reported better-than-expected second-quarter financial results. Additionally, the company issued third-quarter earnings guidance above estimates.</li>
<li>Howmet Aerospace Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) climbed 14.1% to $94.56 following better-than-expected second-quarter earnings, issued strong guidance, raised its dividend, increased its buyback authorization and issued strong guidance.</li>
<li>Repligen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) gained 13.4% to $156.48 following -quarter earnings.</li>
<li>Varonis Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) climbed 13.3% to $54.92 as the company reported better-than-expected second-quarter financial results and raised its FY24 guidance on Monday.</li>
<li>Hayward Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAYW#NYSE">HAYW</a>) gained 11% to $14.98 after the company reported better-than-expected second-quarter EPS results.</li>
<li>F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) shares rose 10.6% to $196.46 after the company reported better-than-expected third-quarter financial results and raised its FY24 earnings guidance above estimates.</li>
<li>Pharming Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) shares gained 9.8% to $8.28. Pharming Group will report second quarter financial results on Aug. 1.</li>
<li>PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) climbed 8.5% to $63.98 after the company reported better-than-expected second quarter financial results.</li>
<li>Stanley Black &amp; Decker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>) rose 8.1% to $104.28 after the company reported better-than-expected second quarter financial results. Additionally, the company revised its FY24 adjusted EPS forecast upward.</li>
<li>Gartner, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) gained 6.4% to $500.83 following better-than-expected quarterly earnings.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>QXO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QXO#NASDAQ">QXO</a>) shares fell 80.8% to $11.44. This sudden decline was triggered by the registration of two private placements with the U.S. Securities and Exchange Commission, which unlocked millions of shares and led to increased selling pressure, Bloomberg reported on Tuesday.</li>
<li>VBI Vaccines Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBIV#NASDAQ">VBIV</a>) declined 64.8% to $0.1960 after the company was granted protection under Canada&#8217;s CCAA by the Ontario Superior Court. The company received approval for a DIP loan, and Ernst &amp; Young was appointed as the monitor during the restructuring process.</li>
<li>CNS Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSP#NASDAQ">CNSP</a>) dipped 40.8% to $0.6158 after the company announced it entered into an exclusive license agreement with Cortice Biosciences.</li>
<li>BIMI Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIMI#NASDAQ">BIMI</a>) tumbled 37% to $0.73.</li>
<li>Bloomz Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMZ#NASDAQ">BLMZ</a>) dipped 30.7% to $1.78.</li>
<li>Ekso Bionics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) fell 26.6% to $1.0901 after the company reported worse-than-expected quarterly sales results.</li>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares declined 25.2% to $12.27 after declining 4% on Monday.</li>
<li>VSee Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEE#NASDAQ">VSEE</a>) fell 23.3% to $2.7999.</li>
<li>SmartRent, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) dipped 21.5% to $1.8850 after the company announced a CEO resignation and suspended its 2024 outlook.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) shares fell 21.1% to $28.13 after the company reported worse-than-expected third-quarter earnings results and issued fourth-quarter revenue guidance below estimates.</li>
<li>Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) fell 16.5% to $152.91 after the company reported mixed third-quarter financial results and lowered its FY24 revenue guidance below estimates.</li>
<li>NIP Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIPG#NASDAQ">NIPG</a>) fell 16.2% to $13.82. NIP Group announced the closing of its initial public offering and partial exercise of underwriters' option to purchase additional ADSs.</li>
<li>Merchants Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBIN#NASDAQ">MBIN</a>) dipped 16.2% to $43.68 after the company reported worse-than-expected quarterly financial results. Additionally, Raymond James downgraded the stock.</li>
<li>Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) shares fell 14.2% to $32.24 after the company issued roughly in-line guidance.</li>
<li>OneWater Marine Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEW#NASDAQ">ONEW</a>) dipped 13.2% to $26.43 after the company reported worse-than-expected third-quarter financial results and issued weak guidance.</li>
<li>Celldex Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLDX#NASDAQ">CLDX</a>) shares fell 11.6% to $37.06 after reporting Phase 2 results for barzolvolimab in chronic inducible urticaria.</li>
<li>Transcat, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRNS#NASDAQ">TRNS</a>) declined 11.2% to $120.00 following weak quarterly sales.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) dipped 9.7% to $233.65 following reports indicating Delta Air Lines would seek compensation from the cybersecurity company for last week&#8217;s outage.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares dipped 9.3% to $50.61 following weak quarterly sales.</li>
<li>Corning Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) fell 8.7% to $38.99 following second-quarter results.</li>
<li>Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) shares fell 8.3% to $50.40 after the company reported worse-than-expected second-quarter financial results and issued weak third-quarter revenue guidance.</li>
<li>Ecolab Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) declined 6.7% to $231.31 after the company reported worse-than-expected second-quarter sales results.</li>
<li>The Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) fell 6.2% to $159.37 following a quarterly revenue miss.</li>
<li>Diageo plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEO#NYSE">DEO</a>) fell 5.5% to $124.30 after the company missed annual profit expectations.</li>
<li>Fresenius Medical Care AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMS#NYSE">FMS</a>) shares declined 4.5% to $19.45 following weak quarterly sales.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/40039797/top-3-health-care-stocks-you-may-want-to-dump-this-quarter">Top 3 Health Care Stocks You May Want To Dump This Quarter</a></li>
</ul>

Intraday Update

Markets

Movers

AMKR

ATPC

BIMI

BLMZ

CALC

CLDX

CNSP

CRWD

CVLT

EKSO

ENVB

FFIV

HAYW

HLIT

IMNN

INVO

ISPO

JBLU

JTAI

LSCC

LUMN

MBIN

NIPG

NVAX

ONEW

PCSA

PHAR

PYPL

RGEN

RMBS

SMRT

TLRY

TRNS

TWOU

VBIV

VSEE

Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Wedbush analyst Daniel Ives maintains Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Outperform and raises the price target from $65 to $67.

Wedbush Maintains Outperform on Varonis Systems, Raises Price Target to $67

TD Cowen analyst Shaul Eyal maintains Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Buy and raises the price target from $54 to $65.

TD Cowen Maintains Buy on Varonis Systems, Raises Price Target to $65

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-ratings/">analyst ratings page</a>.
<ul>
<li>Keefe, Bruyette &amp; Woods cut Principal Financial Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NYSE">PFG</a>) price target from $88 to $86. <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58da738bb85e9300014639dd/ryan-krueger">Keefe, Bruyette &amp; Woods analyst Ryan Krueger</a> maintained a Market Perform rating. Principal Financial shares closed at $81.43 on Monday. <a href="https://www.benzinga.com/quote/PFG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised the price target for Hologic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOLX#NASDAQ">HOLX</a>) from $91 to $95. <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6363d9392048c30001610cbe/casey-woodring">JP Morgan analyst Casey Woodring</a> maintained an Overweight rating. Hologic shares closed at $79.64 on Monday. <a href="https://www.benzinga.com/quote/HOLX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital boosted the price target for F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) from $182 to $205. <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5880b6f377f9dd00011b0ab2/matthew-hedberg">RBC Capital analyst Matthew Hedberg</a> maintained a Sector Perform rating. F5 shares closed at $177.59 on Monday. <a href="https://www.benzinga.com/quote/FFIV/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities boosted the price target for Varonis Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) from $55 to $60.<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/57fdefd3ac6af40001334e3e/joel-fishbein"> Truist Securities analyst Joel Fishbein</a> reiterated a Buy rating. Varonis shares closed at $48.49 on Monday. <a href="https://www.benzinga.com/quote/VRNS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Wells Fargo boosted Universal Health Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UHS#NYSE">UHS</a>) price target from $200 to $255. <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6062fb3160c58c00018c213e/stephen-baxter">Wells Fargo analyst Stephen Baxter</a> maintained an Overweight rating. Universal Health shares closed at $217.43 on Monday. <a href="https://www.benzinga.com/quote/UHS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Benchmark increased the price target for ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) from $80 to $90. <a href="https://widgets.benzinga.com/analyst-stock-ratings/analyst/60216a57879cba00010f246b/david-williams">Benchmark analyst David Williams</a> maintained a Buy rating. ON Semiconductor shares closed at $78.27 on Monday. <a href="https://www.benzinga.com/quote/ON/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Susquehanna increased Royal Caribbean Cruises Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) price target from $160 to $180.<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e99cf3ed89aa400014fa918/christopher-stathoulopoulos"> Susquehanna analyst Christopher Stathoulopoulos</a> maintained a Positive rating. Royal Caribbean Cruises shares closed at $155.14 on Monday. <a href="https://www.benzinga.com/quote/RCL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays boosted Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) price target from $480 to $505. <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5ae1f1fb1fe0110001f9176e/david-strauss">Barclays analyst David Strauss </a>maintained an Equal-Weight rating. Lockheed Martin shares closed at $527.64 on Monday. <a href="https://www.benzinga.com/quote/LMT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham raised Amkor Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMKR#NASDAQ">AMKR</a>) price target from $40 to $45. <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/60ed6112b473c600014bf1c9/charles-shi">Needham analyst Charles Shi</a> maintained a Buy rating. Amkor Technology shares closed at $37.60 on Monday. <a href="https://www.benzinga.com/quote/AMKR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays boosted GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) price target from $175 to $200. <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/585808edee7bf60001bcfa26/julian-mitchell">Barclays analyst Julian Mitchell</a> maintained an Overweight rating. GE Aerospace shares closed at $169.87 on Monday. <a href="https://www.benzinga.com/quote/GE/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/40038432/mcdonalds-analysts-cut-their-forecasts-after-downbeat-earnings">McDonald&#8217;s Analysts Cut Their Forecasts After Downbeat Earnings</a></li>
</ul>

HOLX

GE Aerospace To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday

U.S. stocks were mixed, with the Dow Jones index gaining more than 100 points on Tuesday.
Shares of PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) rose sharply during Tuesday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/07/40034498/fintech-giant-paypals-q2-earnings-revenue-and-eps-beat-payment-volumes-and-transactions-surge-guida">second quarter financial results</a>.
PayPal reported fiscal second-quarter revenue growth of 8% year over year to $7.89 billion, beating the analyst consensus estimate of $7.81 billion. The company reported a quarterly adjusted EPS of $1.19, beating analyst consensus estimates of 98 cents, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
PayPal shares surged 8.5% to $63.98 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>JetBlue Airways Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) jumped 20.6% to $7.16 after the company reported better-than-expected second-quarter financial results.</li>
<li>Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) jumped 19.1% to $2.3050.</li>
<li>Commvault Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) jumped 19.1% to $146.77 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates. Also, the company raised its FY25 revenue guidance.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) jumped 18.8% to $13.96 after the company reported better-than-expected second-quarter financial results and issued third-quarter revenue guidance above estimates.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) shares rose 15.9% to $98.13 after the company reported better-than-expected second-quarter financial results and issued its third-quarter earnings guidance above estimates.</li>
<li>NeoGenomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEO#NASDAQ">NEO</a>) rose 16.1% to $17.00 following upbeat earnings.</li>
<li>Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) rose 16.1% to $2.1250 after the company reported better-than-expected quarterly financial results.</li>
<li>Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) climbed 15.5% to $97.79 after the company reported better-than-expected second-quarter financial results. Additionally, the company issued third-quarter earnings guidance above estimates.</li>
<li>Howmet Aerospace Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) gained 14.1% to $94.56 following better-than-expected second-quarter earnings, issued strong guidance, raised its dividend, increased its buyback authorization and issued strong guidance.</li>
<li>Repligen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) rose 13.4% to $156.48 following -quarter earnings.</li>
<li>Varonis Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) jumped 13.3% to $54.92 as the company reported better-than-expected second-quarter financial results and raised its FY24 guidance on Monday.</li>
<li>Hayward Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAYW#NYSE">HAYW</a>) rose 11% to $14.98 after the company reported better-than-expected second-quarter EPS results.</li>
<li>F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) shares climbed 10.6% to $196.46 after the company reported better-than-expected third-quarter financial results and raised its FY24 earnings guidance above estimates.</li>
<li>Heidrick &amp; Struggles International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSII#NASDAQ">HSII</a>) gained 10.2% to $39.41 following upbeat quarterly results.</li>
<li>Pharming Group N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) shares rose 9.8% to $8.28. Pharming Group will report second quarter financial results on Aug. 1.</li>
<li>CNO Financial Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) jumped 9% to $33.78 following upbeat quarterly results.</li>
<li>Latham Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) surged 8.6% to $3.78.</li>
<li>Stanley Black &amp; Decker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>) gained 8.1% to $104.28 after the company reported better-than-expected second quarter financial results. Additionally, the company revised its FY24 adjusted EPS forecast upward.</li>
<li>Eagle Materials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXP#NYSE">EXP</a>) jumped 8.1% to $268.95 after the company reported better-than-expected first-quarter EPS results.</li>
<li>NovoCure Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVCR#NASDAQ">NVCR</a>) rose 8% to $22.47.</li>
<li>Spirit Airlines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) gained 7.3% to $3.0802. Spirit Airlines announced low-fare travel with new premium offerings starting Aug. 2024.</li>
<li>Zebra Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>) jumped 6.4% to $356.62 after the company reported better-than-expected quarterly financial results. Additionally, the company raised its FY24 guidance.</li>
<li>Gartner, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) rose 6.4% to $500.83 following better-than-expected quarterly earnings.</li>
<li>Phillips 66 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSX#NYSE">PSX</a>) climbed 4.9% to $147.31 after the company reported better-than-expected quarterly financial results.</li>
<li>Pegasystems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGA#NASDAQ">PEGA</a>) gained 4.8% to $69.13.</li>
<li>American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) gained 4.3% to $10.88.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/40038432/mcdonalds-analysts-cut-their-forecasts-after-downbeat-earnings">McDonald&#8217;s Analysts Cut Their Forecasts After Downbeat Earnings</a></li>
</ul>

HSII

NVCR

PEGA

SAVE

SWIM

ZBRA

PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday

RBC Capital analyst Matthew Hedberg maintains Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Outperform and raises the price target from $58 to $65.

RBC Capital Maintains Outperform on Varonis Systems, Raises Price Target to $65

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/topic/edward-kelly">Wells Fargo analyst Edward Kelly</a> upgraded the rating for Sprouts Farmers Market, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFM#NASDAQ">SFM</a>) from Underweight to Equal-Weight and raised the price target from $62 to $90. Sprouts Farmers Market shares settled at $84.66 on Monday. See how other analysts view this stock. <a href="https://www.benzinga.com/quote/SFM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/634fc93b2048c3000154adda/shrenik-kothari">Baird analyst Shrenik Kothari</a> upgraded Varonis Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) from Neutral to Outperform, while increasing the price target from $52 to $60. Varonis shares closed at $48.49 on Monday. <a href="https://www.benzinga.com/quote/VRNS/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/quote/BCS/analyst-ratings">Barclays analyst Simon Coles</a> upgraded the rating for ASML Holding N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) from Equal-Weight to Overweight. ASML shares settled at $870.55 on Monday. <a href="https://www.benzinga.com/quote/ASML/analyst-ratings">See how other analysts view this stock</a>.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58502bd1ee7bf6000190796d/meyer-shields">Keefe, Bruyette &amp; Woods analyst Meyer Shields</a> upgraded Aon plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AON#NYSE">AON</a>) from Underperform to Outperform and boosted the price target from $313 to $380. Aon shares closed at $319.29 on Monday. <a href="https://www.benzinga.com/quote/AON/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587e3d805064ed0001730328/jason-kupferberg">B of A Securities analyst Jason Kupferberg</a> upgraded the rating for Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) from Neutral to Buy, while maintaining the price target of $36. Affirm shares settled at $26.84 on Monday. <a href="https://www.benzinga.com/quote/AFRM/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Check This Out: &lt;a href=&#8221;https://www.benzinga.com/news/earnings/24/04/38307310/d-r-horton-netflix-and-3-stocks-to-watch-heading-into-thursday&#8221;&gt;&lt;em&gt; D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday &lt;/em&gt;&lt;/a&gt;

Upgrades

AFRM

ASML

This ASML Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) reported better-than-expected second-quarter financial results and <a href="https://www.benzinga.com/quote/VRNS/earnings">raised its FY24 guidance on Monday.</a>
Varonis Systems reported quarterly earnings of 5 cents per share which beat the analyst consensus estimate for a loss of 2 cents per share. The company reported quarterly sales of $130.346 million which beat the analyst consensus estimate of $124.842 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Varonis raised its FY24 revenue guidance from $536 million &#8211; $546 million to $544 million &#8211; $552 million. The company boosted adjusted earnings outlook from 13 cents-16 cents per share to 22 cents-24 cents per share.
Varonis Systems shares gained 0.1% to close at $48.49 on Monday.
These analysts made changes to their price targets on Varonis Systems following the announcement.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/634fc93b2048c3000154adda/shrenik-kothari">Baird analyst Shrenik Kothari</a> upgraded Varonis from Neutral to Outperform and raised the price target from $52 to $60.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/590783e6290fa70001409b4a/rob-owens">Piper Sandler analyst Rob Owens</a> maintained the stock with a Neutral and raised the price target from $45 to $48.</li>
<li><a href="https://www.benzinga.com/topic/shyam-patil">Susquehanna analyst Shyam Patil</a> maintained Varonis with a Positive rating, while raising the price target from $55 to $65.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/586f8e4a72b34c0001c9b134/saket-kalia">Barclays analyst Saket Kalia</a> maintained Varonis with an Overweight and boosted the price target from $55 to $60.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/57fdefd3ac6af40001334e3e/joel-fishbein">Truist Securities analyst Joel Fishbein</a> reiterated Varonis with a Buy and raised the price target from $55 to $60.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58a3019243eaaa00011f4050/andrew-nowinski">Wells Fargo analyst Andrew Nowinski</a> maintained the stock with an Equal-Weight and increased the price target from $45 to $48.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/40029782/us-stocks-close-mixed-ahead-of-big-earnings-fed-decision-investor-optimism-improves-further">US Stocks Close Mixed Ahead Of Big Earnings, Fed Decision: Investor Optimism Improves Further</a></li>
</ul>

Earnings

These Analysts Raise Their Forecasts On Varonis Systems Following Upbeat Results

Wells Fargo analyst Andrew Nowinski maintains Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Equal-Weight and raises the price target from $45 to $48.

Wells Fargo Maintains Equal-Weight on Varonis Systems, Raises Price Target to $48

Truist Securities analyst Joel Fishbein reiterates Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Buy and raises the price target from $55 to $60.

Truist Securities Reiterates Buy on Varonis Systems, Raises Price Target to $60

Barclays analyst Saket Kalia maintains Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Overweight and raises the price target from $55 to $60.

Barclays Maintains Overweight on Varonis Systems, Raises Price Target to $60

Needham analyst Alex Henderson has maintained their neutral stance on VRNS stock, giving a Hold rating today. Alex Henderson has given his Hold rat...

Varonis Systems: Hold Rating Amid Strong Growth and Longer-Term Uncertainties

Morgan Stanley analyst Hamza Fodderwala maintained a Buy rating on Varonis Systems (VRNS – Research Report) today and set a price target of $60.00....

Morgan Stanley Sticks to Its Buy Rating for Varonis Systems (VRNS)

Varonis vaults following Q2 results reflecting SaaS momentum

Varonis Systems: Firing On All Cylinders

Analyst Rudy Kessinger from D.A. Davidson maintained a Hold rating on Varonis Systems (VRNS – Research Report) and increased the price target to $4...

Maintaining Hold on Varonis Systems Amidst SaaS Transition Uncertainties and Growth Concerns

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Varonis Systems (VRNS – Research Report), Alkami T...

Analysts' Opinions Are Mixed on These Technology Stocks: Varonis Systems (VRNS), Alkami Technology (ALKT) and Garmin (GRMN)

The 10 most actionable policies if Harris wins this November - Jefferies

Varonis Systems dips on plans to offer $350M convertible debt

Varonis Systems prices $400M senior notes

In a report released today, Saket Kalia from Barclays maintained a Buy rating on Varonis Systems (VRNS – Research Report), with a price target of $...

Barclays Keeps Their Buy Rating on Varonis Systems (VRNS)

ALGM

ALKT

ALLY

AMKBY

ARCB

AVGO

BRKR

CPAY

CYBR

FSLR

GRMN

INTC

LFUS

MRVL

NVDA

ODFL

PANW

PCAR

SAIA

STAG

STLD

VALE

VSEC

Press Releases

Global Cybersecurity Market Size Expected to Reach $298 Billion By 2028 as Cyber Threats Skyrocket

Varonis Announces Date of Second Quarter 2024 Financial Results

Varonis at Black Hat USA 2024: Deploying Copilots Safely and Reducing Your AI Blast Radius

Varonis Announces Second Quarter 2024 Financial Results

General

Varonis Announces AI-Powered Data Discovery and Classification

Varonis Announces Integrations with SentinelOne and Microsoft Defender for Endpoint

Varonis to Present at Upcoming Investor Conference

Financing

Varonis Systems, Inc. Announces Proposed Offering of $350 Million of Convertible Senior Notes

Varonis Systems, Inc. Announces Pricing of its Upsized $400 Million of Convertible Senior Notes

Comments

Varonis Systems

매도 수량

Varonis Systems (NASDAQ:VRNS) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌